Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper EGYPT.

[1]  Sheng-Nan Lu,et al.  Clinical implications of alpha-fetoprotein in chronic hepatitis C. , 2009, Journal of the Formosan Medical Association = Taiwan yi zhi.

[2]  Chien-Hua Chen,et al.  Clinical significance of elevated alpha-fetoprotein (AFP) in chronic hepatitis C without hepatocellular carcinoma. , 2008, Hepato-gastroenterology.

[3]  B. McMahon,et al.  Clinical significance of elevated alpha‐fetoprotein in Alaskan Native patients with chronic hepatitis C , 2007, Journal of viral hepatitis.

[4]  M. Tsai,et al.  Predictors of alpha‐fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a–ribavirin combination therapy , 2007, Journal of gastroenterology and hepatology.

[5]  Sheng-Nan Lu,et al.  Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinoma , 2006, Cancer.

[6]  T. Ide,et al.  A Decrease in AFP Level Related to Administration of Interferon in Patients with Chronic Hepatitis C and a High Level of AFP , 2006, Digestive diseases and sciences.

[7]  M. Mohamed,et al.  Hepatocellular carcinoma in Egypt: a single center study over a decade. , 2005, World journal of gastroenterology.

[8]  Raymond T Chung,et al.  Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. , 2005, Journal of hepatology.

[9]  B. McMahon,et al.  Estimating the Date of Hepatitis C Virus Infection from Patient Interviews and Antibody Tests on Stored Sera , 2004, American Journal of Gastroenterology.

[10]  N. Lim,et al.  Clinical Significance of Elevated Alpha-Fetoprotein (AFP) in Patients with Chronic Hepatitis C, but not Hepatocellular Carcinoma , 2004, American Journal of Gastroenterology.

[11]  L. Mimms,et al.  Highly Sensitive Multiplex Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA , 2002, Journal of Clinical Microbiology.

[12]  Qiuping Guo,et al.  A new class of homogeneous nucleic acid probes based on specific displacement hybridization. , 2002, Nucleic acids research.

[13]  Jing-Houng Wang,et al.  Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan , 2001, Journal of medical virology.

[14]  F. Chang,et al.  Clinical, Virologic, and Pathologic Significance of Elevated Serum Alpha-fetoprotein Levels in Patients with Chronic Hepatitis C , 2001, Journal of clinical gastroenterology.

[15]  S. Gordon,et al.  Serum alpha-fetoprotein levels and liver histology in patients with chronic hepatitis C , 1998, American Journal of Gastroenterology.

[16]  A. Bhalla,et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. , 1997, Gastroenterology.

[17]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[18]  M. Tong,et al.  Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.

[19]  S. Nagataki,et al.  Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. , 1993, The New England journal of medicine.

[20]  K. Migita,et al.  Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus , 2010, Journal of Gastroenterology.

[21]  Sheng-Nan Lu,et al.  Hepatitis C virus genotypes: clinical relevance and therapeutic implications. , 2008, Chang Gung medical journal.

[22]  N. Saunders.  Real-time PCR. , 2004, Methods in molecular biology.

[23]  D. Persing,et al.  Diagnostic molecular microbiology : principles and applications , 1993 .